P&A partners Denis Serkin and Michael S. Zicherman served as co-editors and authors of Lexology's Panoramic: Construction 2027 – US and Global guide. Formerly Getting the Deal Through, Lexology Panoramic provides members of the construction industry and construction-related legal and business providers with side-by-side comparison of key industry issues in 19 jurisdictions worldwide. For the complete guide, click here. Read More

Levi W. Barrett, Co-Managing Partner of Peckar & Abramson's New Jersey office, Co-Chair of the firm's Construction Contracts & Risk Management team, and Executive Committee Member, was recently quoted in "New York Orders Moratorium on Large Data Center Permits," an article written by Engineering News-Record (ENR). The article examines New York Governor Kathy Hochul’s executive order temporarily halting state environmental [...] Read More

Citing prohibitive compliance costs and bureaucratic burdens, on July 13, 2026, the DoD announced the immediate suspension of the rollout of its Cybersecurity Maturity Model Certification (CMMC) program and the implementation of Phase 2, which was scheduled to begin on November 10, 2026. Effective immediately: As a condition of contract award, procuring agencies may only require a contractor to hold [...] Read More

Following the Department of Labor’s 2023 Davis-Bacon rule changes, federal construction contractors faced a pressing question: not whether paying prevailing wages is required, but how far those obligations could extend. Could they reach off-site material suppliers? Delivery drivers? Contracts that omitted Davis-Bacon clauses entirely? A recent federal court decision in AGC of America v. US Department of Labor answers these [...] Read More

Brian D. Waller, Chair of Peckar & Abramson’s White Collar, Regulatory Compliance & Investigations practice, and Co-chair of the firm’s Crisis Management team, was recently quoted in "How Engineers Will Determine Why NYC's Pfizer HQ Conversion Buckled," an article written by Engineering News-Record (ENR). This article examines the ongoing investigation into the structural failure at the former Pfizer headquarters redevelopment [...] Read More